AMERICAN HEALTHCARE REIT INC (AHR) Fundamental Analysis & Valuation

NYSE:AHR • US3981823038

52.37 USD
-0.53 (-1%)
At close: Mar 3, 2026
52.37 USD
0 (0%)
After Hours: 3/3/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This AHR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

Taking everything into account, AHR scores 3 out of 10 in our fundamental rating. AHR was compared to 122 industry peers in the Diversified REITs industry. While AHR is still in line with the averages on profitability rating, there are concerns on its financial health. AHR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. AHR Profitability Analysis

1.1 Basic Checks

  • AHR had positive earnings in the past year.
  • AHR had a positive operating cash flow in the past year.
  • AHR had negative earnings in each of the past 5 years.
  • Of the past 5 years AHR 4 years had a positive operating cash flow.
AHR Yearly Net Income VS EBIT VS OCF VS FCFAHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

  • With a Return On Assets value of 0.57%, AHR perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
  • The Return On Equity of AHR (1.02%) is comparable to the rest of the industry.
  • AHR has a Return On Invested Capital (3.09%) which is comparable to the rest of the industry.
  • AHR had an Average Return On Invested Capital over the past 3 years of 1.94%. This is in line with the industry average of 3.10%.
  • The 3 year average ROIC (1.94%) for AHR is below the current ROIC(3.09%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.57%
ROE 1.02%
ROIC 3.09%
ROA(3y)-1.37%
ROA(5y)N/A
ROE(3y)-4.37%
ROE(5y)N/A
ROIC(3y)1.94%
ROIC(5y)N/A
AHR Yearly ROA, ROE, ROICAHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 2 -2 -4

1.3 Margins

  • With a Profit Margin value of 1.24%, AHR perfoms like the industry average, outperforming 41.80% of the companies in the same industry.
  • Looking at the Operating Margin, with a value of 7.70%, AHR is doing worse than 79.51% of the companies in the same industry.
  • In the last couple of years the Operating Margin of AHR has grown nicely.
  • AHR has a Gross Margin of 20.69%. This is amonst the worse of the industry: AHR underperforms 91.80% of its industry peers.
  • AHR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.7%
PM (TTM) 1.24%
GM 20.69%
OM growth 3Y31.86%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.79%
GM growth 5YN/A
AHR Yearly Profit, Operating, Gross MarginsAHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. AHR Health Analysis

2.1 Basic Checks

  • AHR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • There is no outstanding debt for AHR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
AHR Yearly Shares OutstandingAHR Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 50M 100M 150M
AHR Yearly Total Debt VS Total AssetsAHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • An Altman-Z score of 2.93 indicates that AHR is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • AHR has a better Altman-Z score (2.93) than 95.90% of its industry peers.
  • AHR has a Debt/Equity ratio of 0.58. This is a neutral value indicating AHR is somewhat dependend on debt financing.
  • The Debt to Equity ratio of AHR (0.58) is better than 85.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Altman-Z 2.93
ROIC/WACC0.39
WACC7.91%
AHR Yearly LT Debt VS Equity VS FCFAHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

  • A Current Ratio of 0.76 indicates that AHR may have some problems paying its short term obligations.
  • AHR has a Current ratio of 0.76. This is comparable to the rest of the industry: AHR outperforms 40.98% of its industry peers.
  • A Quick Ratio of 0.76 indicates that AHR may have some problems paying its short term obligations.
  • AHR's Quick ratio of 0.76 is in line compared to the rest of the industry. AHR outperforms 44.26% of its industry peers.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.76
AHR Yearly Current Assets VS Current LiabilitesAHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. AHR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 296.30% over the past year.
EPS 1Y (TTM)296.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%128.57%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11.3%

3.2 Future

  • AHR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.13% yearly.
  • AHR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.21% yearly.
EPS Next Y37.97%
EPS Next 2Y50.34%
EPS Next 3Y29.13%
EPS Next 5YN/A
Revenue Next Year17%
Revenue Next 2Y13.94%
Revenue Next 3Y10.62%
Revenue Next 5Y17.21%

3.3 Evolution

AHR Yearly Revenue VS EstimatesAHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
AHR Yearly EPS VS EstimatesAHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 1

More info and screens

Find the best growth stocksShow best growing peers

1

4. AHR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 98.81, which means the current valuation is very expensive for AHR.
  • Compared to the rest of the industry, the Price/Earnings ratio of AHR is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Earnings ratio of 26.83, AHR is valued quite expensively.
  • The Price/Forward Earnings ratio is 71.62, which means the current valuation is very expensive for AHR.
  • AHR's Price/Forward Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 24.95. AHR is valued rather expensively when compared to this.
Industry RankSector Rank
PE 98.81
Fwd PE 71.62
AHR Price Earnings VS Forward Price EarningsAHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AHR indicates a rather expensive valuation: AHR more expensive than 93.44% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 32.3
AHR Per share dataAHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • AHR's earnings are expected to grow with 29.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.6
PEG (5Y)N/A
EPS Next 2Y50.34%
EPS Next 3Y29.13%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

1

5. AHR Dividend Analysis

5.1 Amount

  • AHR has a Yearly Dividend Yield of 1.91%. Purely for dividend investing, there may be better candidates out there.
  • With a Dividend Yield of 1.91, AHR pays less dividend than the industry average, which is at 7.07. 86.89% of the companies listed in the same industry pay a better dividend than AHR!
  • AHR's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.91%

5.2 History

  • AHR is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
AHR Yearly Dividends per shareAHR Yearly Dividends per shareYearly Dividends per share 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • 583.20% of the earnings are spent on dividend by AHR. This is not a sustainable payout ratio.
DP583.2%
EPS Next 2Y50.34%
EPS Next 3Y29.13%
AHR Yearly Income VS Free CF VS DividendAHR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 0 50M -50M 100M -100M
AHR Dividend Payout.AHR Dividend Payout, showing the Payout Ratio.AHR Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

AHR Fundamentals: All Metrics, Ratios and Statistics

AMERICAN HEALTHCARE REIT INC

NYSE:AHR (3/3/2026, 8:04:00 PM)

After market: 52.37 0 (0%)

52.37

-0.53 (-1%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-26
Earnings (Next)05-04
Inst Owners84.5%
Inst Owner Change15.05%
Ins Owners0.73%
Ins Owner Change-11.92%
Market Cap9.85B
Revenue(TTM)N/A
Net Income(TTM)27.26M
Analysts83.53
Price Target57.2 (9.22%)
Short Float %12.42%
Short Ratio8.61
Dividend
Industry RankSector Rank
Dividend Yield 1.91%
Yearly Dividend1.08
Dividend Growth(5Y)N/A
DP583.2%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)43.29%
Min EPS beat(2)33.28%
Max EPS beat(2)53.31%
EPS beat(4)3
Avg EPS beat(4)-50.49%
Min EPS beat(4)-359.9%
Max EPS beat(4)71.36%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.6%
Min Revenue beat(2)-1.37%
Max Revenue beat(2)2.57%
Revenue beat(4)1
Avg Revenue beat(4)0.2%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)2.57%
Revenue beat(8)4
Avg Revenue beat(8)0.94%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.01%
PT rev (3m)7.32%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.5%
EPS NY rev (1m)0%
EPS NY rev (3m)34.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.43%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)1.97%
Valuation
Industry RankSector Rank
PE 98.81
Fwd PE 71.62
P/S 4.48
P/FCF N/A
P/OCF 32.96
P/B 3.68
P/tB 4.35
EV/EBITDA 32.3
EPS(TTM)0.53
EY1.01%
EPS(NY)0.73
Fwd EY1.4%
FCF(TTM)-0.85
FCFYN/A
OCF(TTM)1.59
OCFY3.03%
SpS11.69
BVpS14.24
TBVpS12.03
PEG (NY)2.6
PEG (5Y)N/A
Graham Number13.03
Profitability
Industry RankSector Rank
ROA 0.57%
ROE 1.02%
ROCE 3.91%
ROIC 3.09%
ROICexc 3.2%
ROICexgc 3.59%
OM 7.7%
PM (TTM) 1.24%
GM 20.69%
FCFM N/A
ROA(3y)-1.37%
ROA(5y)N/A
ROE(3y)-4.37%
ROE(5y)N/A
ROIC(3y)1.94%
ROIC(5y)N/A
ROICexc(3y)1.97%
ROICexc(5y)N/A
ROICexgc(3y)2.22%
ROICexgc(5y)N/A
ROCE(3y)2.45%
ROCE(5y)N/A
ROICexgc growth 3Y56.38%
ROICexgc growth 5YN/A
ROICexc growth 3Y56.96%
ROICexc growth 5YN/A
OM growth 3Y31.86%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.79%
GM growth 5YN/A
F-Score8
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Debt/EBITDA 4.46
Cap/Depr 256.07%
Cap/Sales 20.86%
Interest Coverage 1.95
Cash Conversion 85.75%
Profit Quality N/A
Current Ratio 0.76
Quick Ratio 0.76
Altman-Z 2.93
F-Score8
WACC7.91%
ROIC/WACC0.39
Cap/Depr(3y)83.56%
Cap/Depr(5y)N/A
Cap/Sales(3y)7.98%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)296.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%128.57%
EPS Next Y37.97%
EPS Next 2Y50.34%
EPS Next 3Y29.13%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11.3%
Revenue Next Year17%
Revenue Next 2Y13.94%
Revenue Next 3Y10.62%
Revenue Next 5Y17.21%
EBIT growth 1Y34.52%
EBIT growth 3Y54.7%
EBIT growth 5YN/A
EBIT Next Year163.85%
EBIT Next 3Y55.66%
EBIT Next 5Y38.05%
FCF growth 1Y151.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y78.71%
OCF growth 3Y114.22%
OCF growth 5YN/A

AMERICAN HEALTHCARE REIT INC / AHR FAQ

What is the ChartMill fundamental rating of AMERICAN HEALTHCARE REIT INC (AHR) stock?

ChartMill assigns a fundamental rating of 3 / 10 to AHR.


Can you provide the valuation status for AMERICAN HEALTHCARE REIT INC?

ChartMill assigns a valuation rating of 1 / 10 to AMERICAN HEALTHCARE REIT INC (AHR). This can be considered as Overvalued.


What is the profitability of AHR stock?

AMERICAN HEALTHCARE REIT INC (AHR) has a profitability rating of 4 / 10.


What is the expected EPS growth for AMERICAN HEALTHCARE REIT INC (AHR) stock?

The Earnings per Share (EPS) of AMERICAN HEALTHCARE REIT INC (AHR) is expected to grow by 37.97% in the next year.


How sustainable is the dividend of AMERICAN HEALTHCARE REIT INC (AHR) stock?

The dividend rating of AMERICAN HEALTHCARE REIT INC (AHR) is 1 / 10 and the dividend payout ratio is 583.2%.